Oxidative mechanisms are believed to play an important role in the pat
hogenesis of age-related eye disease, in particular, cataract and macu
lar degeneration, the two most important causes of visual impairment i
n older adults. For this reason, there is considerable interest in det
ermining whether vitamins and trace minerals with antioxidant properti
es can be of benefit in preventing the onset or progression of disabli
ng eye disease. Basic research studies have shown that antioxidants ca
n protect against the cumulative effects of oxidative stress in animal
models of cataract and macular degeneration. Data from observational
epidemiologic studies in humans, however, are inconclusive. While resu
lts from several studies, primarily cross-sectional and case-control,
are compatible with a possible protective role for micronutrients in c
ataract and macular degeneration, data for specific nutrients or speci
fic disease types have often been inconsistent. Further, these observa
tional studies are Limited because of the inherent imprecision of diet
ary exposure data and the likely effects of uncontrolled confounding.
Thus, reliable data regarding a potentially important benefit of vitam
in supplementation in eye disease will emerge mainly from well-designe
d, large-scale, randomized trials. Such data are already being collect
ed in the National Eye Institute-sponsored Age Related Eye Disease Stu
dy, as well as in the Physicians' Health Study and Women's Health Stud
y.